Intravenous Paracetamol Dosing and Administration
For pediatric patients, use a loading dose of 15-20 mg/kg followed by maintenance doses of 10-15 mg/kg every 6-8 hours (maximum 60 mg/kg/day), while adults should receive 1000 mg every 6 hours (maximum 4 g/day), with dose reductions required for patients <50 kg and neonates requiring age-specific adjustments. 1
Pediatric Dosing Guidelines
Children and Adolescents (≥2 years)
- Loading dose: 15-20 mg/kg IV (using 10 mg/mL preparation) 1
- Maintenance dose: 10-15 mg/kg every 6-8 hours 1
- Maximum daily dose: 60 mg/kg/day 1
- Administration: Infuse over 15 minutes 2, 3
The European Society for Paediatric Anaesthesiology specifically recommends these weight-based dosing regimens for postoperative pain management, emphasizing that IV paracetamol should be combined with NSAIDs when possible to reduce opioid requirements 1.
Neonates and Infants (<2 years)
Term neonates (≥37 weeks gestational age):
- Loading dose: 20 mg/kg 4
- Maintenance: 10 mg/kg every 6 hours 4
- This regimen achieves target steady-state concentrations of 9-11 mg/L for effective analgesia 4
Preterm neonates (32-37 weeks):
Very preterm neonates (<32 weeks):
- Loading dose: 12 mg/kg 4
- Maintenance: 6 mg/kg every 6 hours 4
- Lower doses are necessary due to immature hepatic metabolism and prolonged elimination half-life 4
Infants (29 days to <2 years):
- Dose: 12.5 mg/kg every 6 hours 3
- This achieves plasma concentrations similar to standard adult dosing 3
Adult Dosing Guidelines
Standard Adult Dosing (≥50 kg)
- Dose: 1000 mg IV every 6 hours 5
- Maximum daily dose: 4000 mg (4 g) 5
- Administration: Infuse over 15 minutes 6
Adults <50 kg
- Dose: 15 mg/kg every 6 hours 2, 3
- Maximum daily dose: 60 mg/kg or 3000 mg, whichever is less 5
- Weight-based dosing is critical in this population to avoid underdosing 5
High-Dose Regimens (Immediate Postoperative Period)
For severe acute postoperative pain in adults, a higher initial dose may be considered:
- Loading dose: 2000 mg IV over 15 minutes 6
- Maintenance: 1000 mg every 6 hours for total of 5 g in first 24 hours 6
- This regimen achieved peak concentrations of 67.9 ± 21.8 μg/mL without reaching toxic levels and showed no hepatotoxicity in healthy subjects 6
Special Populations and Considerations
Hepatic Impairment
- Patients with documented liver disease can receive standard doses with appropriate monitoring 5
- In a postmarketing review, 10 patients (3%) with liver disease received IV paracetamol without adverse effects or liver function test elevations 5
- However, exercise caution and consider dose reduction or extended dosing intervals in severe hepatic impairment 7
Pregnancy
- Standard adult dosing can be used 8
- Paracetamol crosses the placenta but is considered safe when used appropriately 8
Obesity (>100 kg)
- Use actual body weight for dosing calculations up to maximum of 1000 mg per dose 8
- Do not exceed 4000 mg daily regardless of weight 8
Administration Technique
- Infusion time: 15 minutes for all doses 2, 3, 6
- Preparation: Available as 10 mg/mL solution 1
- Compatibility: Can be administered alone or with other analgesics including NSAIDs and opioids 1, 5
Clinical Integration
Multimodal Analgesia
Paracetamol should be combined with NSAIDs whenever possible to optimize pain control and reduce opioid consumption 1. The European guidelines emphasize using both agents throughout the postoperative period rather than as monotherapy 1.
Duration of Therapy
- Most patients receive IV paracetamol for ≤24 hours 5
- In the postmarketing review, 22% of patients received therapy >24 hours without safety concerns 5
- Transition to oral formulation as soon as clinically appropriate 1
Safety Profile
Adverse Effects
IV paracetamol demonstrates excellent tolerability:
- In a study of 300 patients, no adverse effects (including commonly reported nausea, vomiting, headache, or insomnia) were documented 5
- Pediatric studies showed similar safety profiles with significantly fewer treatment discontinuations compared to placebo 3
Hepatotoxicity Risk
Critical dosing thresholds to prevent hepatotoxicity:
- Never exceed 4000 mg/day in adults 5, 8
- Never exceed 60 mg/kg/day in children 1
- Verify patient is not taking other paracetamol-containing products 7, 8
The 2011 FDA mandate limiting paracetamol to 325 mg/tablet in combination products was associated with an 11% yearly decrease in hospitalizations for paracetamol/opioid toxicity and a 16% yearly decrease in acute liver failure cases 9.
Common Pitfalls to Avoid
Underdosing patients <50 kg: Always use weight-based dosing (15 mg/kg) rather than fixed adult doses 5
Incorrect neonatal dosing: Preterm neonates require substantially lower doses than term neonates due to immature metabolism 4
Overlooking concurrent paracetamol sources: Always verify the patient is not receiving oral or rectal paracetamol or taking combination products containing paracetamol 7, 8
Inappropriate dosing intervals: Maintain 6-hour intervals for standard dosing; shorter intervals risk accumulation and toxicity 1, 5
Monotherapy in moderate-to-severe pain: Paracetamol should be part of multimodal analgesia, not sole therapy for significant pain 1